CY2523B1 - Tetrahydropyran derivatives - Google Patents

Tetrahydropyran derivatives

Info

Publication number
CY2523B1
CY2523B1 CY0500023A CY0500023A CY2523B1 CY 2523 B1 CY2523 B1 CY 2523B1 CY 0500023 A CY0500023 A CY 0500023A CY 0500023 A CY0500023 A CY 0500023A CY 2523 B1 CY2523 B1 CY 2523B1
Authority
CY
Cyprus
Prior art keywords
hydroxy groups
antiinflammatory
free
tetrahydropyran derivatives
various
Prior art date
Application number
CY0500023A
Other languages
English (en)
Inventor
A R C Murty Bulusu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939310975A external-priority patent/GB9310975D0/en
Priority claimed from GB939310969A external-priority patent/GB9310969D0/en
Priority claimed from GB939312590A external-priority patent/GB9312590D0/en
Priority claimed from GB939313553A external-priority patent/GB9313553D0/en
Priority claimed from GB939319618A external-priority patent/GB9319618D0/en
Priority claimed from GB939319617A external-priority patent/GB9319617D0/en
Priority claimed from GB939326045A external-priority patent/GB9326045D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY2523B1 publication Critical patent/CY2523B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Color Printing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CY0500023A 1993-05-27 2005-04-14 Tetrahydropyran derivatives CY2523B1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB939310975A GB9310975D0 (en) 1993-05-27 1993-05-27 Organic compounds
GB939310969A GB9310969D0 (en) 1993-05-27 1993-05-27 Organic compounds
GB939312590A GB9312590D0 (en) 1993-06-18 1993-06-18 Organic compounds
GB939313553A GB9313553D0 (en) 1993-07-01 1993-07-01 Organic compounds
GB939319618A GB9319618D0 (en) 1993-09-23 1993-09-23 Organic compounds
GB939319617A GB9319617D0 (en) 1993-09-23 1993-09-23 Organic compounds
GB939326045A GB9326045D0 (en) 1993-12-21 1993-12-21 Organic compounds

Publications (1)

Publication Number Publication Date
CY2523B1 true CY2523B1 (en) 2006-02-08

Family

ID=27562893

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0500023A CY2523B1 (en) 1993-05-27 2005-04-14 Tetrahydropyran derivatives

Country Status (24)

Country Link
US (1) US5493019A (ja)
EP (1) EP0626385B1 (ja)
JP (1) JP3076724B2 (ja)
CN (1) CN1048495C (ja)
AT (1) ATE252105T1 (ja)
AU (1) AU682499B2 (ja)
CA (1) CA2124260C (ja)
CY (1) CY2523B1 (ja)
CZ (1) CZ286157B6 (ja)
DE (1) DE69433234T2 (ja)
DK (1) DK0626385T3 (ja)
ES (1) ES2208651T3 (ja)
FI (1) FI107159B (ja)
HK (1) HK1011684A1 (ja)
HU (1) HU218919B (ja)
IL (1) IL109775A (ja)
MY (1) MY110603A (ja)
NO (1) NO308302B1 (ja)
NZ (1) NZ260596A (ja)
PH (1) PH30420A (ja)
PT (1) PT626385E (ja)
RU (1) RU2130460C1 (ja)
SI (1) SI0626385T1 (ja)
SK (1) SK281541B6 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089233C (zh) 1994-10-26 2002-08-21 诺瓦蒂斯有限公司 药物组合物
EP1023441A1 (en) 1997-10-16 2000-08-02 The Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
KR100505464B1 (ko) 1998-03-26 2005-08-04 후지사와 야꾸힝 고교 가부시키가이샤 서방성 제제
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
WO2004009056A1 (en) 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
JP2007516951A (ja) * 2003-12-30 2007-06-28 アステラス製薬株式会社 気道閉塞症の治療または予防のためのマクロライドの使用
GT200500282A (es) 2004-10-12 2006-05-04 Heteroatomos conteniendo compuestos triciclicos.
EP1688161A1 (en) * 2004-11-02 2006-08-09 Switch Biotech Aktiengesellschaft Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
RU2543721C2 (ru) * 2009-07-15 2015-03-10 СиТиАй БИОФАРМА КОРП. Цитратная соль 9е-15-(2-пирролидин-1-ил-этокси)-7,12,25-триокса-19,21,24-триазатетрацикло[18.3.1.1(2,5).1(14,18)]гексакоза-1(24),2,4,9,14,16,18(26),20,22-нонаена
JPWO2016068208A1 (ja) 2014-10-28 2017-08-10 晃史 山口 妊娠状態を改善するための薬剤及びその利用
WO2020032252A1 (ja) 2018-08-10 2020-02-13 晃史 山口 母体と胎児との関係における液性免疫関連疾患の治療薬
WO2020129348A1 (ja) 2018-12-18 2020-06-25 晃史 山口 不妊・不育症または妊娠状態を改善するための薬剤
CN113614091A (zh) * 2019-01-23 2021-11-05 约翰霍普金斯大学 非免疫抑制性fk506类似物及其用途
WO2022139524A1 (ko) * 2020-12-24 2022-06-30 서울대학교산학협력단 신규 fk506 유도체 및 이를 포함하는 발모 촉진용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0078235A3 (de) * 1981-10-23 1983-06-29 Ciba-Geigy Ag Dihalogenierte Steroide
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CH677448A5 (ja) * 1987-11-09 1991-05-31 Sandoz Ag
EP0385936A1 (de) * 1989-02-27 1990-09-05 Ciba-Geigy Ag Peptidlacton und derivate davon, Verfahren zu ihrer Herstellung und Mittel zur Ausführung des Verfahrens
JPH05505798A (ja) * 1990-03-13 1993-08-26 フアイソンズ・ピーエルシー 免疫抑制マクロ環状化合物
CA2051872A1 (en) * 1990-09-24 1992-03-25 Kevin M. Byrne Directed biosynthesis process for prolyl-immunomycin
GB2249787A (en) * 1990-11-19 1992-05-20 Fujisawa Pharmaceutical Co Lactone compounds
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
JP3036923B2 (ja) * 1991-10-28 2000-04-24 理化学研究所 デプシペプチドａ、ｂその製造方法、並びに抗ウイルス剤及び抗菌剤
HUT66531A (en) * 1992-05-07 1994-12-28 Sandoz Ag Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them

Also Published As

Publication number Publication date
JPH06340672A (ja) 1994-12-13
HU9401582D0 (en) 1994-08-29
EP0626385A1 (en) 1994-11-30
AU682499B2 (en) 1997-10-09
SK281541B6 (sk) 2001-04-09
SI0626385T1 (en) 2004-02-29
ATE252105T1 (de) 2003-11-15
NZ260596A (en) 1995-10-26
DK0626385T3 (da) 2004-02-16
CN1048495C (zh) 2000-01-19
CN1099756A (zh) 1995-03-08
MY110603A (en) 1998-08-29
CA2124260A1 (en) 1994-11-28
CZ129594A3 (en) 1995-01-18
PH30420A (en) 1997-05-09
AU6331794A (en) 1994-12-01
NO308302B1 (no) 2000-08-28
EP0626385B1 (en) 2003-10-15
IL109775A0 (en) 1994-08-26
HU218919B (hu) 2000-12-28
DE69433234D1 (de) 2003-11-20
PT626385E (pt) 2004-03-31
HUT71396A (en) 1995-11-28
US5493019A (en) 1996-02-20
RU2130460C1 (ru) 1999-05-20
FI942444A (fi) 1994-11-28
JP3076724B2 (ja) 2000-08-14
NO941936D0 (no) 1994-05-25
CZ286157B6 (cs) 2000-01-12
HK1011684A1 (en) 1999-07-16
FI942444A0 (fi) 1994-05-25
SK61194A3 (en) 1995-02-08
NO941936L (no) 1994-11-28
ES2208651T3 (es) 2004-06-16
IL109775A (en) 1999-07-14
FI107159B (fi) 2001-06-15
CA2124260C (en) 2007-04-17
DE69433234T2 (de) 2004-08-05

Similar Documents

Publication Publication Date Title
CY2523B1 (en) Tetrahydropyran derivatives
PL300068A1 (en) 9-(substituted glycil) amido-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts or metal complexes, pharmaceutical agent and veterinari agent
RU94018524A (ru) Производные тетрагидропирана, способ их получения и фармацевтическая композиция на их основе
AU3839393A (en) Improvements in or relating to organic compounds
ZA954074B (en) Acylated aminoalkanimidazoles and -triazoles
AU2704492A (en) Improvements in or relating to organic compounds
TW235294B (ja)
TW232007B (ja)
AU5491094A (en) 1,2-Dioxane compounds